Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago

Possible Interaction: Flufenamic Acid and Calcium Supplement

Research Papers that Mention the Interaction

“Three TAS2R14 agonists, flufenamic acid , chlorhexidine, and diphenhydramine, also evoked rises in intracellular calcium in TCL.”
American journal of physiology. Regulatory, integrative and comparative physiology  •  2019  |  View Paper
“ Flufenamic acid commonly not only affects non-selective cation channels and chloride channels, but also modulates potassium, calcium and sodium channels with effective concentrations ranging from 10(-6)M in TRPM4 channel inhibition to 10(-3)M in two-pore outwardly rectifying potassium channel activation.”
Pharmacology & therapeutics  •  2013  |  View Paper
“The two fenamates inhibited the increases in intracellular free calcium concentration induced by either the chemotactic peptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine or the calcium ionophore A23187 in fura-2-labeled PMNs.”
Molecular pharmacology  •  1995  |  View Paper
“It requires an increase in postsynaptic calcium for activation, and is blocked by flufenamic acid , an antagonist of a previously identified calcium activated non-selective cation channel (I(CAN)).”
Brain Research  •  2010  |  View Paper
“In mouse olfactory epithelium, we found that >80% of the summated electrical response to odors is blocked by niflumic acid or flufenamic acid , each of which inhibits Ca2+ -activated Cl- channels in ORNs.”
Journal of neurophysiology  •  2006  |  View Paper
“In contrast flufenamic acid (100 μM), an inhibitor of non‐selective cation channels, genistein (10 μM), a broad‐range tyrosine kinase inhibitor, and piceatannol (10 μM), an inhibitor specific for non‐receptor Syk tyrosine kinase, inhibited CCE during ACh decay but not during Ca2+ reintroduction.”
The Journal of physiology  •  1999  |  View Paper
“It was concluded that flufenamic acid was affecting calcium movements across the mitochondrial membrane by virtue of its ability to uncouple oxidative phosphorylation.”
“The anti-inflammatory agent flufenamic acid was found to inhibit calcium uptake in isolated mitochondria at low concentrations (IC50 = 7.2 microM).”
Biochemical pharmacology  •  1988  |  View Paper